Quantification of cobimetinib, cabozantinib, dabrafenib, niraparib, olaparib, vemurafenib, regorafenib and its metabolite regorafenib M2 in human plasma by UPLC–MS/MS

著者: Krens, Stefanie D., van der Meulen, Eric, Jansman, Frank G.A., Burger, David M., van Erp, Nielka P.
出版年 Biomed Chromatogr (2020)

Development and validation of a bioanalytical method to quantitate enzalutamide and its active metabolite N-desmethylenzalutamide in human plasma: application to clinical managemen...

著者: Benoist, Guillemette E, van der Meulen, Eric, van Oort, Inge M, Beumer, Jan Hendrik, Somford, Diederik M, Schalken, Jack A, Burger, David M, van Erp, Nielka P
出版年 Ther Drug Monit (2018)

Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasma

著者: Benoist, Guillemette E., van der Meulen, Eric, Lubberman, Floor J. E., Gerritsen, Winald R., Smilde, Tineke J., Schalken, Jack A., Beumer, Jan H., Burger, David M., van Erp, Nielka P.
出版年 Biomed Chromatogr (2017)